09:15 AM EDT, 07/09/2024 (MT Newswires) -- Health care stocks were slightly higher premarket Tuesday as the Health Care Select Sector SPDR Fund ( XLV ) and the iShares Biotechnology ETF ( IBB ) were both up 0.2% recently.

Indivior ( INDV ) declined by over 38% after saying it now expects fiscal 2024 net revenue to be in a range of $1.15 billion to $1.22 billion, down from its prior outlook of $1.24 billion to $1.33 billion.

Kymera Therapeutics ( KYMR ) rose past 11% after saying Sanofi ( SNY ) has informed it of the plan to expand the ongoing Hidradenitis Suppurativa and Atopic Dermatitis mid-stage trials to more rapidly progress towards pivotal studies.

Grifols ( GRFS ) was nearly 5% higher after a regulatory filing showed that the company's founding family and private equity fund Brookfield (BN) are considering a bid to take the drugmaker private.